Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maternal obesity induces macrophage to myofibroblast transition in kidneys of male offspring through a pathway driven by 20-hydroxyeicosatetraenoic acid. | Nat Commun | 2026 | 42135322 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease: Shared Mechanisms and Therapeutic Opportunities. | Cardiol Rev | 2026 | 42121355 | PubTator, text mining | PubMed |
| Correction: A high-fructose diet leads to osteoporosis by suppressing the expression of Thrb and facilitating the accumulation of cholesterol. | Cell Death Discov | 2026 | 42086544 | PubTator, text mining | PubMed |
| THRB splice site variants lead to exon 4 skipping and TRβ1 gain-of-function syndrome. | medRxiv | 2026 | 42078357 | PubTator, text mining | PubMed |
| A case of resistance to thyroid hormone beta and literature review: Case report. | Medicine (Baltimore) | 2026 | 42065173 | PubTator, text mining | PubMed |
THR-β Agonists vs Incretin Therapies for Noncirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Biopsy-Anchored Systematic Review With Grading of Recommendations Assessment, Development and Evaluation (GRADE) Certainty. | Cureus | 2026 | 42051839 | PubTator, text mining | PubMed |
| Deciphering cytochrome P450 reductase role in MASLD: molecular mechanisms and pathophysiological implications. | Nat Rev Gastroenterol Hepatol | 2026 | 42009939 | PubTator, text mining | PubMed |
| The human THRB thyroid hormone receptor gene and the puzzle of retinal disease phenotypes. | Dev Biol | 2026 | 41997342 | PubTator, text mining | PubMed |
| Downregulation of THRB drives immune microenvironment suppression and poor outcomes, acting as a dual biomarker for clear cell renal cell carcinoma. | BMC Cancer | 2026 | 41981494 | PubTator, text mining | PubMed |
| The specific features of the thyroid hormone receptor gene THRB polymorphism in indigenous populations of Siberia. | Vavilovskii Zhurnal Genet Selektsii | 2026 | 41971652 | PubTator, text mining | PubMed |
| A case of thyroid hormone resistance with coincidental pituitary macroadenoma. | JCEM Case Rep | 2026 | 41971634 | PubTator, text mining | PubMed |
| A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: From mechanism to therapy. | Mol Ther | 2026 | 41964221 | PubTator, text mining | PubMed |
| Development and validation of a novel analytical method for related substances of resmetirom and identification of new degradation products. | Front Chem | 2026 | 41953937 | PubTator, text mining | PubMed |
| Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis of Randomized Controlled Trials. | Endocrinol Diabetes Metab | 2026 | 41947319 | PubTator, text mining | PubMed |
| Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials. | Intern Emerg Med | 2026 | 41917519 | PubTator, text mining | PubMed |
| Macrophage β-catenin-Ihh axis induces hepatic stellate cell activation and fibrosis in metabolic dysfunction-associated steatohepatitis. | Inflamm Res | 2026 | 41896378 | PubTator, text mining | PubMed |
| Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial. | J Hepatol | 2026 | 41895606 | PubTator, text mining | PubMed |
| CRISPR and Beyond: Genome-Editing Strategies in Retinal Stem Cell Research. | Cells | 2026 | 41892280 | PubTator, text mining | PubMed |
| Effect of Essential Phospholipids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial. | Liver Int | 2026 | 41889076 | PubTator, text mining | PubMed |
| Metabolic dysfunction-associated steatotic liver disease: Integrating metabolic and hepatic management into pharmacy practice. | Am J Health Syst Pharm | 2026 | 41885169 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=3